Keyword Analysis & Research: reflexion medical
Keyword Research: People who searched reflexion medical also searched
Search Results related to reflexion medical on Search Engine
-
Home Page - RefleXion
https://reflexion.com/
WebNew codes and payment expected to facilitate clinical adoption of novel cancer treatment option HAYWARD, Calif., Jan. 11, 2024 – RefleXion Medical, Inc., a therapeutic oncology company, today announced that the Centers for Medicare and Medicaid Services (CMS) has established a national payment rate for RefleXion’s SCINTIX® biology-guided ...
DA: 92 PA: 55 MOZ Rank: 20
-
Our Company - RefleXion
https://reflexion.com/our-company/
WebRefleXion forms a multidisciplinary scientific advisory board, comprising 10 medical experts from radiation oncology, medical oncology and nuclear medicine. Recognition RefleXion Wins 2022 Pantheon Award
DA: 71 PA: 90 MOZ Rank: 14
-
RefleXion Announces Initial Close of $105M Fundraising to …
https://finance.yahoo.com/news/reflexion-announces-initial-close-105m-140100446.html
WebHAYWARD, Calif., November 15, 2023 -- ( BUSINESS WIRE )-- RefleXion Medical, a therapeutic oncology company, today announced the initial closing of a $105M equity raise, led by The Rise Fund,...
DA: 7 PA: 63 MOZ Rank: 31
-
RefleXion Receives FDA Clearance for SCINTIX Biology-Guided
https://reflexion.com/press-releases/reflexion-receives-fda-clearance-for-scintix-biology-guided-radiotherapy-cutting-edge-treatment-applicable-for-early-and-late-stage-cancers/
WebHAYWARD, Calif., Feb. 2, 2023 – RefleXion Medical, a therapeutic oncology company, today announced the U.S. Food and Drug Administration (FDA) has granted the first marketing clearance for its SCINTIX™ biology-guided radiotherapy, a cutting-edge treatment applicable for early and late-stage cancers. The company will host a live-stream event ...
DA: 97 PA: 95 MOZ Rank: 22
-
RefleXion nets $105M to roll out its PET-guided cancer radiotherapy
https://www.fiercebiotech.com/medtech/pet-guided-radiotherapy-green-light-hand-reflexion-raises-105m-commercial-push
WebNov 15, 2023 · (RefleXion Medical) After winning an FDA clearance earlier this year for its image-guided radiation treatment for cancer, RefleXion Medical has raised $105 million to boost commercialization...
DA: 66 PA: 99 MOZ Rank: 20
-
RefleXion Medical | LinkedIn
https://www.linkedin.com/company/reflexion-medical
WebRefleXion Medical | LinkedIn. Medical Equipment Manufacturing. Hayward, CA 12,710 followers. SCINTIX biology-guided radiotherapy is now FDA cleared. See jobs Follow. View all 242 employees....
DA: 100 PA: 41 MOZ Rank: 73
-
RefleXion Acquires Global Rights to Radiopharmaceutical …
https://finance.yahoo.com/news/reflexion-acquires-global-rights-radiopharmaceutical-130000849.html
WebSep 20, 2023 · HAYWARD, Calif. & BERLIN, September 20, 2023--RefleXion Medical, Inc., a therapeutic oncology company and 3B Pharmaceuticals (3BP) GmbH, a biotechnology company developing targeted...
DA: 36 PA: 97 MOZ Rank: 81
-
RefleXion Raises $80 Million to Broaden Cancer Treatment Options
https://www.businesswire.com/news/home/20220310005028/en/RefleXion-Raises-80-Million-to-Broaden-Cancer-Treatment-Options
WebMar 10, 2022 · About RefleXion Medical. RefleXion is a privately-held company developing the first biology-guided radiotherapy system, a significant change in strategy from single tumor therapy to the ability...
DA: 91 PA: 42 MOZ Rank: 94
-
RefleXion snags FDA breakthrough status for cancer-guided …
https://www.fiercebiotech.com/medtech/reflexion-snags-fda-breakthrough-status-for-cancer-guided-radiotherapy-to-treat-lung-tumors
WebDec 6, 2021 · RefleXion Medical is aiming to develop radiation therapy capable of destroying metastatic tumors—by using the cancer itself as a tour guide through the areas of the body where it has already...
DA: 76 PA: 89 MOZ Rank: 39
-
RefleXion Announces Initial Close of $105M Fundraising to
https://www.biospace.com/article/releases/reflexion-announces-initial-close-of-105m-fundraising-to-commercialize-new-cancer-treatment/
WebNov 15, 2023 · About RefleXion Medical. RefleXion is a privately held therapeutic oncology company located in Hayward, Calif., commercializing SCINTIX biology-guided radiotherapy, a novel therapy that uses a single radiotracer injection to transform cancer cells into real-time biological beacons to control external-beam radiotherapy delivery to multiple tumors.
DA: 64 PA: 35 MOZ Rank: 92